Silence Therapeutics Plc

(NASDAQ) SLN

Current Price$6.11

Market Cap$288.13M

Since IPO (2020)-69%

5 Year-76%

1 Year+52%

1 Month-16%

Silence Therapeutics Plc Financials at a Glance

Market Cap

$288.13M

Revenue (TTM)

$838.29K

Net Income (TTM)

$75.01M

EPS (TTM)

$-1.59

P/E Ratio

-3.83

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$6.11

Volume

11,943

Open

$7.01

Price

$6.11

Volume

11,943

Open

$7.01

Previous Close

$6.11

Daily Range

$6.08 - $7.10

52-Week Range

$4.19 - $8.40

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$6.11

Volume

11,943

Open

$7.01

Previous Close

$6.11

Daily Range

$6.08 - $7.10

52-Week Range

$4.19 - $8.40

SLN News

Silence (SLN) Q2 Revenue Drops 71%

Motley Fool Markets TeamAug 7, 2025

SLN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Silence Therapeutics Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Iain Gladstone Ross

Website

www.silence-therapeutics.com

Headquarters

London, W14 8TH, GB

SLN Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

-93%

Net Income Margin

-89%

Return on Equity

-93%

Return on Capital

-74%

Return on Assets

-65%

Earnings Yield

-26.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$288.13M

Shares Outstanding

47.23M

Volume

11.94K

Avg. Volume

323.08K

Financials (TTM)

Gross Profit

$344.00K

Operating Income

$89.75M

EBITDA

$89.20M

Operating Cash Flow

$62.27M

Capital Expenditure

$55.00K

Free Cash Flow

$62.33M

Cash & ST Invst.

$85.11M

Total Debt

$160.00K

Silence Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$421.29K

+196.7%

Gross Profit

$304.49K

+246.0%

Gross Margin

72.27%

N/A

Market Cap

$288.13M

N/A

Market Cap/Employee

$2.48M

N/A

Employees

116

N/A

Net Income

$14.93M

+47.7%

EBITDA

$14.91M

+47.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$69.94M

-48.8%

Accounts Receivable

$22.22M

+31.9%

Inventory

$0.00

N/A

Long Term Debt

$43.00K

N/A

Short Term Debt

$93.00K

+55.0%

Return on Assets

-65.16%

N/A

Return on Invested Capital

-74.23%

N/A

Free Cash Flow

$15.60M

-26.7%

Operating Cash Flow

$15.60M

-26.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.79-0.36%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.56-1.49%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$5.09-7.45%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$9.49-11.64%

LYELLyell Immunopharma, Inc.

LYELLyell Immunopharma, Inc.$17.92-5.78%

ALDXAldeyra Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.$1.68+1.20%

CTNMContineum Therapeutics, Inc. Class A Common Stock

CTNMContineum Therapeutics, Inc. Class A Common Stock$13.72-3.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About SLN

What is the current price of Silence Therapeutics Plc?

Silence Therapeutics Plc is trading at $6.11 per share.

What is the 52-week range for Silence Therapeutics Plc?

Over the past 52 weeks, Silence Therapeutics Plc has traded between $4.19 and $8.40.

How much debt does Silence Therapeutics Plc have?

As of the most recent reporting period, Silence Therapeutics Plc reported total debt of $136,000.

How much cash does Silence Therapeutics Plc have on hand?

Silence Therapeutics Plc reported $5.66M in cash and cash equivalents in its most recent financial results.

What is Silence Therapeutics Plc’s dividend yield?

Silence Therapeutics Plc does not currently have a dividend yield.

Silence Therapeutics Plc

Silence Therapeutics Plc Financials at a Glance

SLN News

Silence (SLN) Q2 Revenue Drops 71%

SLN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Silence Therapeutics Plc

SLN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Silence Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLN

What is the current price of Silence Therapeutics Plc?

What is the 52-week range for Silence Therapeutics Plc?

How much debt does Silence Therapeutics Plc have?

How much cash does Silence Therapeutics Plc have on hand?

What is Silence Therapeutics Plc’s dividend yield?

Premium Investing Services